- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
3-(2-chloropyriMidin-4-yl) -1-Methylindole
Product Name:3-(2-chloropyriMidin-4-yl) -1-Methylindole
Formulae hypotheticae: C13H10ClN3
Molecular pondus:243.69
CAS Registry Number: 1032452-86-0
N-(4-fluoro-2-Methoxy-5-nitrophenyl) -4-(1-Methylindol-3-yl)pyriMidin-2-aMine
Product Name:N.
Formulae hypotheticae: C20H16FN5O3
Molecular pondus:393.37
CAS Registry Number: 1421372-94-2
1,4-BenzenediaMine, N1. -nitro
Product Name:1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl ]-2-nitro
Formulae hypotheticae: C25H29N7O3
Molecular pondus:475.54
CAS Registry Number: 1421372-67-9
Mutatus EGFR-IN-1
Product Name: Mutated EGFR-IN-1
Formulae hypotheticae: C25H31N7O
Molecular pondus:445.56
CAS Registry Number: 1421372-66-8
![2-acidi pyridinecarboxylici, 1-[[[(1,1-dimethylethoxy) carbonyl]amino]-3-(hexyloxy)-1,4-dihydro-4-oxo-](/upload/6698/2-pyridinecarboxylic-acid-1-1-1-dimethylethoxy-carbonyl-amino-3-hexyloxy-1-4-dihydro-4-oxo-_11397.gif "2-acidi pyridinecarboxylici, 1-[[[(1,1-dimethylethoxy) carbonyl]amino]-3-(hexyloxy)-1,4-dihydro-4-oxo-")
2-acidi pyridinecarboxylici, 1-[[[(1,1-dimethylethoxy) carbonyl]amino]-3-(hexyloxy)-1,4-dihydro-4-oxo-
Product Name:2-acidi pyridinecarboxylici, 1-[[[(1,1-dimethylethoxy) carbonyl]amino]-3-(hexyloxy)-1,4-dihydro-4-oxo-
Formulae hypotheticae: C17H26N2O6
Molecular pondus:354.4
CAS Subcriptio Number:2305694-57-7
![(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4] triazine-6,8-dione](/upload/6698/-12ar-7-hexyloxy-3-4-12-12a-tetrahydro-1h-1-4-oxazino-3-4-c-pyrido-2-1-f-1-2-4-triazine-6-8-dione_417392.gif "(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4] triazine-6,8-dione")
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4] triazine-6,8-dione
Product Name:(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2 triazine-6,8-dione
Formulae hypotheticae: C16H23N3O4
Molecular pondus:321.37
CAS Subcriptio Number:2136287-67-5
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
